Nearly 12% of Medicare patients who receive inpatient rehabilitation following discharge from acute-care hospitalization are readmitted to the hospital within 30 days after discharge from the rehabilitation facility, according to a study in the Feb. 12 issue of the Journal of the American Medical Association.
Nearly 12% of Medicare patients who receive inpatient rehabilitation following discharge from acute-care hospitalization are readmitted to the hospital within 30 days after discharge from the rehabilitation facility, according to a study in the Feb. 12 issue of the Journal of the American Medical Association.
Until recently, there has been a lack of research on frequency and causes of patients returning to hospital after rehabilitation.
The study reports 30-day hospital readmission rates across rehabilitation impairment categories and examines whether readmissions are associated with patient socio-demographics, clinical characteristics, functional status, or facility factors.
Researchers from University of Texas Medical Branch at Galveston evaluated patients from the six largest impairment categories, which represent approximately 75% of Medicare fee-for-service patients receiving inpatient rehabilitation: Stroke, lower extremity fracture, lower extremity joint replacement, debility, neurological disorders, and brain dysfunction.
They analyzed data from Centers for Medicare & Medicaid Services’ (CMS) files covering 1,365 post-acute rehabilitation facilities, representing 736,536 post-acute patients discharged from inpatient rehabilitation facilities from 2006 through 2011. The mean patient age was 78.0 (SD=7.3) years. The majority of patients were female (62.5%) with 85.1% non-Hispanic white. The mean rehabilitation length of stay was 12.4 (SD=5.3) days.
The total 30-day hospital readmission rate among patients discharged from a rehabilitation facility to the community was 11.8%. Among the six impairment categories, lower extremity joint replacement had the lowest readmission rate for patients at 5.8%, while debility had the highest readmission rate at 18.8%. Readmission rates were higher for men and non-Hispanic blacks and for patients with longer lengths of stay. Approximately half of patients included in the study were readmitted within 11 days after discharge.
Researchers noted similar readmission rates between rural and urban facilities and freestanding and hospital-based facilities. Geographic variation of readmission rates varied between 9.2% and 13.6%, with the lowest rates found in Idaho and Washington and the highest rate found in Michigan.
Across the facilities included in the study, study authors noted several diagnosis-related groups readmitted more frequently for all impairment categories, including kidney and urinary tract infections, pneumonia, and nutritional and miscellaneous metabolic disorders.
These findings in particular may represent potential targets for early intervention to reduce readmission rates.
This type of data is important because Medicare is in the process of developing new payment models associated with healthcare reform.
“Currently, Medicare spends $20 billion each year on readmissions of hospitalized older adults,” said lead author Kenneth Ottenbacher, PhD, of the University of Texas Medical Branch at Galveston. “The data uncovered in this study is crucial in order to effectively develop new health reimbursement systems that bundle acute and post-acute care to improve quality and contain costs.”
This year, CMS began using 30-day readmission as a national quality indicator for inpatient rehabilitation facilities.
CVS Caremark Makes Changes in Diabetes Coverage for 2025
Published: November 25th 2024 | Updated: November 25th 2024CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.
Read More
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More